ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 2.200
-0.060 (-2.65%)
At close: Apr 4, 2025
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 21.50M SEK in the twelve months ending December 31, 2024, up 2,527.19% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.
Revenue (ttm)
21.50M
Revenue Growth
+2,527.19%
P/S Ratio
1.98
Revenue / Employee
21.50M
Employees
1
Market Cap
42.65M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 176.78B |
| Atlas Copco AB | 176.77B |
| AB Volvo | 526.82B |
| ASSA ABLOY AB | 150.16B |
| EQT AB | 30.39B |
| Skandinaviska Enskilda Banken AB | 81.00B |
| Telefonaktiebolaget LM Ericsson | 249.58B |
| Swedbank AB | 74.37B |